Most nodules are not cancer. Across the organs where nodules commonly appear, roughly 95% turn out to be benign. That single statistic is the most important thing to know if you’ve just been told a scan found a nodule somewhere in your body. The next most important thing: the specific characteristics of your nodule, where it is, and your personal health history all shape how doctors decide whether it needs further testing or just routine monitoring.
How Often Nodules Are Actually Cancer
The word “nodule” simply means a small, roughly round growth spotted on imaging. It can appear in the lungs, thyroid, adrenal glands, breast, skin, or liver. In almost every location, the odds strongly favor a benign result.
In the lungs, an estimated 1.57 million nodules are found incidentally each year in the United States. About 5% of those are malignant. Even in formal lung cancer screening programs, where patients are already at higher risk, only about 1.1% of screened patients end up diagnosed with lung cancer. For thyroid nodules, the numbers are similar: approximately 95% are benign and only about 5% are cancerous. Adrenal nodules, which show up on 3 to 7% of abdominal scans, carry an even lower risk. One multi-institution study found malignancy in just 1.4% of adrenal nodules overall, and among patients with no prior cancer history, zero malignant adrenal nodules were found.
Breast lumps follow a similar pattern. Many are caused by cysts, fibroadenomas, or normal tissue changes, and the vast majority are not cancer. Skin nodules are also overwhelmingly benign, ranging from dermatofibromas (small scar-like bumps) to dermoid cysts and pyogenic granulomas.
What Causes Benign Nodules
Nodules form for dozens of reasons that have nothing to do with cancer. In the lungs, the most common culprits are old infections that left behind scar tissue, chronic conditions like tuberculosis, autoimmune diseases such as sarcoidosis or rheumatoid arthritis, and prior trauma. Certain fungal infections tied to specific geographic regions also cause lung nodules: histoplasmosis in the Mississippi Valley, Valley Fever in the San Joaquin Valley of California, and blastomycosis near the Great Lakes. Fluid-filled cysts and congenital conditions account for still more.
Thyroid nodules often develop from overgrowth of normal thyroid tissue or from fluid-filled cysts. Hormonal changes, iodine levels, and chronic inflammation of the thyroid gland all play a role. Adrenal nodules are frequently nonfunctioning adenomas, essentially harmless lumps of adrenal tissue that produce no symptoms.
Features That Raise or Lower Cancer Risk
Doctors don’t just look at whether a nodule exists. They evaluate a set of specific features to estimate malignancy risk, and these vary by organ.
Lung Nodules
Size is the single biggest predictor. Nodules smaller than 6 millimeters carry very low risk and often need no follow-up at all. As nodules get larger, risk increases. Location matters too: nodules in the upper lobes of the lung are more suspicious. Irregular or spiky margins (sometimes called “spiculated” edges) raise concern compared to smooth, round shapes. Your personal risk factors, especially age and smoking history, also factor in. Guidelines divide patients into low-risk (less than 5% annual chance of lung cancer) and high-risk (greater than 5%) categories, and the recommended follow-up timeline differs accordingly.
Thyroid Nodules
Ultrasound features drive the risk assessment. Radiologists score nodules based on four key characteristics: irregular margins, darker-than-normal appearance on ultrasound, a shape that is taller than it is wide, and tiny calcium deposits within the nodule. The more of these features present, the more suspicious the nodule, and the lower the size threshold at which doctors recommend a biopsy. A smooth, fluid-filled thyroid nodule with none of these features is very unlikely to be cancer.
Skin Nodules
For skin growths, the ABCDE criteria help distinguish harmless moles from melanoma. Warning signs include asymmetry (one half doesn’t match the other), irregular borders, color that varies across the growth, diameter larger than a pencil eraser, and any evolution in appearance over time. A nodule that is symmetrical, uniform in color, and stable is far less concerning.
How Growth Speed Helps Predict Cancer
One of the most reliable ways to distinguish benign from malignant nodules is tracking how fast they grow. Doctors measure this using “doubling time,” the number of days it takes a nodule to double in volume. For solid lung nodules, a doubling time between 30 and 400 days is the range most associated with cancer. Slower-growing nodules, particularly those with a partly hazy appearance on CT (called subsolid nodules), tend to have doubling times longer than 400 days and are often lower-grade or benign.
The practical takeaway: a lung nodule that stays the same size for two years is generally considered benign. This is why many nodules are managed with periodic CT scans rather than immediate biopsy. Your doctor compares the current scan to previous ones, measuring whether the nodule has grown and how quickly. Stability over time is one of the strongest signs that a nodule is harmless.
What Happens After a Nodule Is Found
The path forward depends on the nodule’s size, appearance, location, and your risk profile. For many small, low-risk nodules, the recommendation is simply to repeat imaging in a few months or a year to check for growth. This “watch and wait” approach is standard, not a sign that something was missed.
If a nodule has suspicious features or has grown, the next step is usually a biopsy. For thyroid nodules, this typically involves fine needle aspiration, a procedure where a thin needle extracts a small sample of cells for examination under a microscope. The false-negative rate for this test is low, around 4% in one study of larger thyroid nodules, meaning it reliably identifies benign nodules as benign. When fine needle aspiration returns a “benign” result, that result is accurate the vast majority of the time.
For lung nodules, biopsy options include needle biopsy through the chest wall or a scope-based procedure through the airways. The choice depends on the nodule’s size and location. In some cases, particularly when cancer risk is high and the nodule is in an accessible spot, doctors may recommend surgical removal rather than biopsy.
When Risk Is Higher
Certain situations do shift the odds. If you have a history of cancer elsewhere in the body, a new nodule in the lung or adrenal gland is more likely to be a metastasis. In the adrenal gland study, 4.7% of nodules in patients with a prior cancer history turned out to be metastatic, compared to 0% in patients without that history. Similarly, larger thyroid nodules (4 centimeters or more) carry a somewhat higher malignancy rate, around 15% in one surgical series, compared to the 5% average for thyroid nodules overall.
Heavy smoking, older age, and a family history of cancer all increase the probability that a lung nodule is malignant. These factors don’t guarantee cancer, but they influence how aggressively doctors pursue testing and how short the interval between follow-up scans will be.
Why “Nodule” Does Not Mean “Tumor”
The language on a radiology report can be alarming. Words like “nodule,” “lesion,” and “opacity” are descriptive terms, not diagnoses. They tell you something was seen on imaging, not what it is. Radiologists use these terms for anything from a tiny scar left by a childhood infection to a cancerous growth, because the imaging alone often cannot tell the difference. The purpose of follow-up, whether that means another scan in six months or a biopsy next week, is to make that distinction. In the overwhelming majority of cases, the answer turns out to be benign.